Makary resigns as FDA commissioner amid pressure over flavored e-cigarettes

What's happened

The FDA commissioner has stepped down after about a year amid tensions over regulatory decisions surrounding flavored e-cigarettes and other policy clashes with the administration and industry.

What's behind the headline?

Key questions for readers

What drove Makary’s resignation? This story centers on policy battles around flavored e-cigarettes and other regulatory moves.
How might leadership changes affect FDA initiatives? Expect continued tension between public health priorities and industry interests.
Who steps in next and what signals will guide policy? Acting commissioner Kyle Diamantas is likely to steer until a permanent replacement is named.

What this signals about FDA direction

The agency is navigating political pressure while trying to maintain scientific principles.
Expect ongoing scrutiny of product approvals and ingredient transparency.
Regulators will continue to balance public-health goals with industry and political expectations.

How we got here

Makary has led the FDA during a period of regulatory reform and staff churn, with decisions on smoking- and vaping-related policy drawing scrutiny from both public-health groups and industry actors. His resignation comes amid disputes over the pace of approvals and the agency’s stance on flavored products.

Our analysis

AP News reports Makary has stepped down after a tumultuous tenure; The New York Times notes policy disputes over flavored e-cigarettes and other leadership tensions; NY Post highlights political backlash and industry lobbying; coverage from multiple outlets underscores a broader political dynamic surrounding FDA leadership.

Go deeper

What will the acting commissioner signal about future flavor-ingredient policies?
Who could be named as the next FDA head, and when might that occur?
How will the departure affect ongoing FDA initiatives on vaping and food-safety regulation?

FDA chief Makary resigns amid e-cigarette policy clash